Tags

Type your tag names separated by a space and hit enter

A Critical Appraisal of the Quality of Glioma Imaging Guidelines Using the AGREE II Tool: A EuroAIM Initiative.
Front Oncol 2019; 9:472FO

Abstract

Background:

Following the EuroAIM initiative to assess the quality of medical imaging guidelines by using the Appraisal of Guidelines for Research and Evaluation (AGREE) II instrument, we aimed to evaluate the quality of the current imaging guidelines in patients with gliomas.

Methods:

A literature search was conducted to identify eligible imaging guidelines considered in the management of adult patients with gliomas. The selected guidelines were evaluated using the AGREE II instrument by four independent appraisers. The agreement among the four appraisers was estimated using the intraclass correlation coefficient (ICC) analysis.

Results:

Seven guidelines were selected for the appraisal. Six out of the seven guidelines showed an average level of quality with only one showing a low quality. The highest scores were found in Domain 1 "Scope and purpose" (mean score = 81.2%) and Domain 4 "Clarity of presentation" (mean score = 77.6%). The remaining domains showed a low level of quality and, in particular, Domain 5 "Applicability" was the most critical with a mean score of 41.7%, mainly related to a minor attention to barriers and facilitators as well as costs and resources implications of applying the guidelines. The ICC analysis showed a very good agreement among the four appraisers with ICC values ranging from 0.907 to 0.993.

Conclusions:

The available guidelines on glioma imaging emerged as of average quality according to the AGREE II tool analysis. Based on these results, further efforts should be made in order to involve different professional bodies and stakeholders and increase patient and public involvement in any future guideline drafting as well as to improve the applicability of these guidelines into the clinical practice.

Authors+Show Affiliations

Department of Advanced Biomedical Sciences, University of Naples "Federico II", Naples, Italy.Department of Advanced Biomedical Sciences, University of Naples "Federico II", Naples, Italy.Department of Advanced Biomedical Sciences, University of Naples "Federico II", Naples, Italy.Department of Advanced Biomedical Sciences, University of Naples "Federico II", Naples, Italy.Department of Advanced Biomedical Sciences, University of Naples "Federico II", Naples, Italy.Medical School, University of Ioannina, Ioannina, Greece. Department of Neuroradiology, The National Hospital for Neurology and Neurosurgery, University College London NHS Foundation Trust, London, United Kingdom.Department of Advanced Biomedical Sciences, University of Naples "Federico II", Naples, Italy.Department of Neuroradiology, The National Hospital for Neurology and Neurosurgery, University College London NHS Foundation Trust, London, United Kingdom. Department of Brain Repair and Rehabilitation, Institute of Neurology, University College London, London, United Kingdom.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

31231610

Citation

Romeo, Valeria, et al. "A Critical Appraisal of the Quality of Glioma Imaging Guidelines Using the AGREE II Tool: a EuroAIM Initiative." Frontiers in Oncology, vol. 9, 2019, p. 472.
Romeo V, Stanzione A, Ugga L, et al. A Critical Appraisal of the Quality of Glioma Imaging Guidelines Using the AGREE II Tool: A EuroAIM Initiative. Front Oncol. 2019;9:472.
Romeo, V., Stanzione, A., Ugga, L., Cuocolo, R., Cocozza, S., Ioannidou, E., ... Bisdas, S. (2019). A Critical Appraisal of the Quality of Glioma Imaging Guidelines Using the AGREE II Tool: A EuroAIM Initiative. Frontiers in Oncology, 9, p. 472. doi:10.3389/fonc.2019.00472.
Romeo V, et al. A Critical Appraisal of the Quality of Glioma Imaging Guidelines Using the AGREE II Tool: a EuroAIM Initiative. Front Oncol. 2019;9:472. PubMed PMID: 31231610.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - A Critical Appraisal of the Quality of Glioma Imaging Guidelines Using the AGREE II Tool: A EuroAIM Initiative. AU - Romeo,Valeria, AU - Stanzione,Arnaldo, AU - Ugga,Lorenzo, AU - Cuocolo,Renato, AU - Cocozza,Sirio, AU - Ioannidou,Evangelia, AU - Brunetti,Arturo, AU - Bisdas,Sotirios, Y1 - 2019/06/07/ PY - 2019/03/14/received PY - 2019/05/16/accepted PY - 2019/6/25/entrez PY - 2019/6/25/pubmed PY - 2019/6/25/medline KW - AGREE II KW - evidence-based medicine KW - glioma KW - guidelines KW - imaging SP - 472 EP - 472 JF - Frontiers in oncology JO - Front Oncol VL - 9 N2 - Background: Following the EuroAIM initiative to assess the quality of medical imaging guidelines by using the Appraisal of Guidelines for Research and Evaluation (AGREE) II instrument, we aimed to evaluate the quality of the current imaging guidelines in patients with gliomas. Methods: A literature search was conducted to identify eligible imaging guidelines considered in the management of adult patients with gliomas. The selected guidelines were evaluated using the AGREE II instrument by four independent appraisers. The agreement among the four appraisers was estimated using the intraclass correlation coefficient (ICC) analysis. Results: Seven guidelines were selected for the appraisal. Six out of the seven guidelines showed an average level of quality with only one showing a low quality. The highest scores were found in Domain 1 "Scope and purpose" (mean score = 81.2%) and Domain 4 "Clarity of presentation" (mean score = 77.6%). The remaining domains showed a low level of quality and, in particular, Domain 5 "Applicability" was the most critical with a mean score of 41.7%, mainly related to a minor attention to barriers and facilitators as well as costs and resources implications of applying the guidelines. The ICC analysis showed a very good agreement among the four appraisers with ICC values ranging from 0.907 to 0.993. Conclusions: The available guidelines on glioma imaging emerged as of average quality according to the AGREE II tool analysis. Based on these results, further efforts should be made in order to involve different professional bodies and stakeholders and increase patient and public involvement in any future guideline drafting as well as to improve the applicability of these guidelines into the clinical practice. SN - 2234-943X UR - https://www.unboundmedicine.com/medline/citation/31231610/A_Critical_Appraisal_of_the_Quality_of_Glioma_Imaging_Guidelines_Using_the_AGREE_II_Tool:_A_EuroAIM_Initiative L2 - https://dx.doi.org/10.3389/fonc.2019.00472 DB - PRIME DP - Unbound Medicine ER -